Lostam BioPharmaceuticals Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Lostam BioPharmaceuticals General Information

Description

Developer of protein therapeutics designed to prevent and treat lethal Gram-negative bacterial infections. The company's protein therapeutics offers a panel of human therapeutic protein candidates and novel pipelines of anti-bacterial drugs capable of combating serious bacterial infections and of withstanding the cunning efforts of bacteria to develop drug-resistant mechanisms, enabling doctors to treat and prevent lethal Gram-negative bacterial infections associated primarily within the hospital setting.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Corporate Office
  • Nazareth Industrial Area
  • PO Box 2252
  • Nazareth 16000
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lostam BioPharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Jul-2017 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view Lostam BioPharmaceuticals’s complete valuation and funding history, request access »

Lostam BioPharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of protein therapeutics designed to prevent and treat lethal Gram-negative bacterial infections. The company's
Biotechnology
Nazareth, Israel
00000000 00

000000

nsequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum d
0000 000000000
Barcelona, Spain
00 As of 0000
000.00
000.00 0000-00-00
0000000 0000 000.00

000 00

at nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa
0000 000000000
Barcelona, Spain
00 As of 0000
0000
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lostam BioPharmaceuticals Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ability Pharma Private Equity-Backed Barcelona, Spain 00 000.00 0000000 0000 000.00
Ona Therapeutics Venture Capital-Backed Barcelona, Spain 00 0000 00000000000 0000
Lung Therapeutics Formerly VC-backed Austin, TX 00 000.00 000000&0 000.00
Genentech Formerly VC-backed South San Francisco, CA 00000 00.000 00000000000 00.000
Volastra Venture Capital-Backed New York, NY 00 00000 00000000000 00000
You’re viewing 5 of 11 competitors. Get the full list »

Lostam BioPharmaceuticals FAQs

  • When was Lostam BioPharmaceuticals founded?

    Lostam BioPharmaceuticals was founded in 2009.

  • Where is Lostam BioPharmaceuticals headquartered?

    Lostam BioPharmaceuticals is headquartered in Nazareth, Israel.

  • What industry is Lostam BioPharmaceuticals in?

    Lostam BioPharmaceuticals’s primary industry is Biotechnology.

  • Is Lostam BioPharmaceuticals a private or public company?

    Lostam BioPharmaceuticals is a Private company.

  • What is Lostam BioPharmaceuticals’s current revenue?

    The current revenue for Lostam BioPharmaceuticals is 000000.

  • Who are Lostam BioPharmaceuticals’s competitors?

    Ability Pharma, Ona Therapeutics, Lung Therapeutics, Genentech, and Volastra are some of the 11 competitors of Lostam BioPharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »